R Conwit

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi request reprint Muscle quality and age: cross-sectional and longitudinal comparisons
    E J Metter
    The National Institute on Aging, Gerontology Research Center, Baltimore, Maryland 21224 6823, USA
    J Gerontol A Biol Sci Med Sci 54:B207-18. 1999
  2. ncbi request reprint Neuroprotective agents for clinical trials in ALS: a systematic assessment
    B J Traynor
    Neurology Clinical Trials Unit, Department of Neurology, Massachusetts General Hospital, Boston, USA
    Neurology 67:20-7. 2006
  3. doi request reprint A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS
    Paul H Gordon
    Department of Neurology, Columbia University, New York, USA
    Amyotroph Lateral Scler 9:212-22. 2008

Detail Information

Publications3

  1. ncbi request reprint Muscle quality and age: cross-sectional and longitudinal comparisons
    E J Metter
    The National Institute on Aging, Gerontology Research Center, Baltimore, Maryland 21224 6823, USA
    J Gerontol A Biol Sci Med Sci 54:B207-18. 1999
    ..In addition, CREAT may measure a muscle property not accounted for by CSA or FFM...
  2. ncbi request reprint Neuroprotective agents for clinical trials in ALS: a systematic assessment
    B J Traynor
    Neurology Clinical Trials Unit, Department of Neurology, Massachusetts General Hospital, Boston, USA
    Neurology 67:20-7. 2006
    ..Riluzole is currently the only Food and Drug Administration-approved treatment for ALS, but its effect on survival is modest...
  3. doi request reprint A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS
    Paul H Gordon
    Department of Neurology, Columbia University, New York, USA
    Amyotroph Lateral Scler 9:212-22. 2008
    ..This phase II design was efficient, leading to treatment selection after just 60 patients, and can be used in other phase II trials to assess different agents...